| scholarly article | Q13442814 |
| P50 | author | Jae-Joon Hwang | Q89179661 |
| Seo Hee Shin | Q89588638 | ||
| Ye Jee Kim | Q89588641 | ||
| Sang Do Lee | Q89588645 | ||
| Cheon Woong Choi | Q89588648 | ||
| Jae Seung Lee | Q89588651 | ||
| Yeon-Mok Oh | Q56532532 | ||
| Yee Hyung Kim | Q85360157 | ||
| P2860 | cites work | Diagnosis and Management of the Antiphospholipid Syndrome | Q88785663 |
| The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study | Q92918227 | ||
| Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data | Q30400752 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Diagnosis and classification of the antiphospholipid syndrome | Q33412887 | ||
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients | Q33412915 | ||
| How I treat catastrophic thrombotic syndromes. | Q33424463 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples | Q34121058 | ||
| The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis | Q36434130 | ||
| Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome | Q37738701 | ||
| Guidelines on the investigation and management of antiphospholipid syndrome | Q37982121 | ||
| 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome | Q38197819 | ||
| Prevalence and incidence of systemic lupus erythematosus in South Korea | Q38423234 | ||
| The antiphospholipid syndrome in patients with systemic lupus erythematosus | Q38806198 | ||
| Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry | Q38957667 | ||
| Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis | Q39502759 | ||
| Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. | Q39612628 | ||
| Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study | Q44326255 | ||
| The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies | Q50263868 | ||
| 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. | Q51289629 | ||
| Management of antiphospholipid syndrome | Q57033429 | ||
| Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study | Q57213603 | ||
| Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects | Q72433855 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | e35 | |
| P577 | publication date | 2020-02-10 | |
| P1433 | published in | Journal of Korean Medical Science | Q24039955 |
| P1476 | title | Epidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based Study | |
| P478 | volume | 35 |
Search more.